EA201590008A1 - Композиции и способы повышения эффективности бактерицидных средств контрацепции - Google Patents
Композиции и способы повышения эффективности бактерицидных средств контрацепцииInfo
- Publication number
- EA201590008A1 EA201590008A1 EA201590008A EA201590008A EA201590008A1 EA 201590008 A1 EA201590008 A1 EA 201590008A1 EA 201590008 A EA201590008 A EA 201590008A EA 201590008 A EA201590008 A EA 201590008A EA 201590008 A1 EA201590008 A1 EA 201590008A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- compositions
- bactericidal
- methods
- contraceptive
- contraceptives
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 5
- 230000000844 anti-bacterial effect Effects 0.000 title abstract 4
- 239000003433 contraceptive agent Substances 0.000 title abstract 4
- 229940124558 contraceptive agent Drugs 0.000 title 1
- 230000002254 contraceptive effect Effects 0.000 abstract 3
- 239000003443 antiviral agent Substances 0.000 abstract 2
- 208000019802 Sexually transmitted disease Diseases 0.000 abstract 1
- 230000002378 acidificating effect Effects 0.000 abstract 1
- 239000003242 anti bacterial agent Substances 0.000 abstract 1
- 230000000840 anti-viral effect Effects 0.000 abstract 1
- 230000009977 dual effect Effects 0.000 abstract 1
- 230000035935 pregnancy Effects 0.000 abstract 1
- 230000002195 synergetic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Virology (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Urology & Nephrology (AREA)
- Inorganic Chemistry (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Orthopedics, Nursing, And Contraception (AREA)
- Dispersion Chemistry (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261659368P | 2012-06-13 | 2012-06-13 | |
| PCT/US2013/032510 WO2013187984A1 (en) | 2012-06-13 | 2013-03-15 | Compositions and methods for enhancing the efficacy of contraceptive microbicides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EA201590008A1 true EA201590008A1 (ru) | 2015-05-29 |
Family
ID=49758600
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA201590008A EA201590008A1 (ru) | 2012-06-13 | 2013-03-15 | Композиции и способы повышения эффективности бактерицидных средств контрацепции |
Country Status (17)
| Country | Link |
|---|---|
| US (7) | US20150202216A1 (enExample) |
| EP (2) | EP3308771A1 (enExample) |
| JP (2) | JP6352907B2 (enExample) |
| KR (1) | KR102062599B1 (enExample) |
| CN (2) | CN104487054A (enExample) |
| AP (1) | AP2014008149A0 (enExample) |
| AU (2) | AU2013274815B2 (enExample) |
| BR (1) | BR112014030984B1 (enExample) |
| EA (1) | EA201590008A1 (enExample) |
| HK (1) | HK1208809A1 (enExample) |
| IL (1) | IL235812B (enExample) |
| MX (2) | MX365905B (enExample) |
| NZ (1) | NZ703203A (enExample) |
| SG (1) | SG11201408243VA (enExample) |
| UA (1) | UA115876C2 (enExample) |
| WO (1) | WO2013187984A1 (enExample) |
| ZA (1) | ZA201500111B (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ703203A (en) * | 2012-06-13 | 2016-07-29 | Evofem Inc | Compositions and methods for enhancing the efficacy of contraceptive microbicides |
| JP2017501227A (ja) | 2013-12-19 | 2017-01-12 | エヴォフェム，インク． | アルギン酸をベースとする抗菌性化合物を使用して炎症と疾患を阻害するための組成物及び方法 |
| AU2017338748A1 (en) * | 2016-10-04 | 2019-05-02 | Evofem Inc. | Method of treatment and prevention of bacterial vaginosis |
| USD920853S1 (en) * | 2018-09-14 | 2021-06-01 | Porsche Lizenz—und Handelsgesellschaft mbH & Co. KG | Bicycle |
| US11850303B2 (en) | 2020-10-27 | 2023-12-26 | Uqora, Inc. | Gel and a suppository and methods to provide the gel and suppository |
Family Cites Families (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1213323B (it) | 1986-08-07 | 1989-12-20 | Crinos Industria Farmaco | Composizione per uso locale ad atti vita' spermicida virulicida ,disinfettante e/o battericida |
| US4999342A (en) * | 1988-08-16 | 1991-03-12 | Ortho Pharmaceutical Corporation | Long lasting contraceptive suppository composition and methods of use |
| JP3202365B2 (ja) | 1992-12-04 | 2001-08-27 | 株式会社紀文フードケミファ | オリゴマンヌロン酸を重合度によって分離する方法 |
| US5592949A (en) | 1994-06-29 | 1997-01-14 | Moench; Thomas R. | Device for acidic buffering and method for inactivation of pathogens |
| US5667492A (en) | 1994-10-07 | 1997-09-16 | Columbia Laboratories, Inc. | Use and composition of an anti-sexually transmitted diseases formulation |
| FR2728464B1 (fr) | 1994-12-22 | 1997-04-30 | Innothera Lab Sa | Forme galenique unitaire, son procede d'obtention et ses utilisations |
| US6093394A (en) | 1997-04-11 | 2000-07-25 | Gynelogix, Inc. | Vaginal lactobacillus medicant |
| AU1661901A (en) | 1999-11-24 | 2001-06-04 | Cargill Dow Llc | Improved lactic acid processing; methods; arrangements; and, products |
| AU2001243431B2 (en) * | 2000-03-07 | 2006-05-25 | Rush University Medical Center | Compositions and methods for trapping and inactivating pathogenic microbes and spermatozoa |
| JP2009102407A (ja) | 2001-03-08 | 2009-05-14 | Rohto Pharmaceut Co Ltd | Ｇリッチなアルギン酸含有組成物 |
| US20020177624A1 (en) | 2001-03-16 | 2002-11-28 | Calvin Hanna | Acetate-lactate buffering vaginal gel and for method of making same and treating bacterial vaginosis |
| ITMI20010913A1 (it) | 2001-05-04 | 2002-11-04 | Univ Pavia | Composizioni a rilascio controllato di acido lattico a livello vaginale |
| EP1399151A4 (en) | 2001-06-11 | 2004-08-04 | Merck & Co Inc | METHOD FOR TREATING INFLAMMABLE DISEASES BY ADMINISTRATING A PPAR DELTA AGONIST |
| US20060105008A1 (en) | 2002-03-28 | 2006-05-18 | Nawaz Ahmad | Compositions and methods for reducing vaginal pH |
| US20130150810A1 (en) | 2002-04-30 | 2013-06-13 | The Population Council, Inc. | Intravaginal ring for the delivery of unique combinations of antimicrobial compositions |
| JP4712380B2 (ja) | 2002-07-26 | 2011-06-29 | 三笠製薬株式会社 | 外用剤 |
| US7820145B2 (en) | 2003-08-04 | 2010-10-26 | Foamix Ltd. | Oleaginous pharmaceutical and cosmetic foam |
| BRPI0411429A (pt) | 2003-06-13 | 2006-07-25 | Idh Holding Aps | tratamento de sintomas associados com vaginose bacteriana |
| US20050272700A1 (en) | 2004-05-10 | 2005-12-08 | Servet Buyuktimkin | Topical treatment and prevention of human papilloma virus (HPV) infection |
| RU2257197C1 (ru) | 2004-05-12 | 2005-07-27 | Дулькис Мария Дмитриевна | Вагинальные суппозитории, обладающие контрацептивным действием |
| UA93354C2 (ru) * | 2004-07-09 | 2011-02-10 | Гилиад Сайенсиз, Инк. | Местный противовирусный препарат |
| JPWO2008056786A1 (ja) | 2006-11-10 | 2010-02-25 | ロート製薬株式会社 | 皮膚又は粘膜適用組成物 |
| US7659259B2 (en) | 2006-12-21 | 2010-02-09 | Bausch & Lomb Incorporated | Method of treating inflammation of the eye |
| CN101677980B (zh) | 2007-03-30 | 2013-10-23 | 莱克瑞股份公司 | 乳酸低聚物在制备用于治疗妇科病的药物中的应用 |
| AU2008256689A1 (en) | 2007-05-24 | 2008-12-04 | New York Blood Center Inc. | Rapidly dispersible vaginal tablet that provides a bioadhesive gel |
| WO2009003189A1 (en) | 2007-06-27 | 2008-12-31 | Acresso Software, Inc. | A method and system for software virtualization directly from an installation package |
| TW200927141A (en) | 2007-11-22 | 2009-07-01 | Bayer Schering Pharma Oy | Vaginal delivery system |
| KR20110003534A (ko) * | 2008-04-16 | 2011-01-12 | 시플라 리미티드 | 항진균제 및 항바이러스제를 포함하는 국소 조합물 |
| CN101559036B (zh) * | 2008-04-18 | 2012-02-08 | 上海医药工业研究院 | 一种阴道用避孕凝胶组合物及其制备方法和应用 |
| WO2009155118A1 (en) | 2008-05-30 | 2009-12-23 | Reprotect, Inc. | Compositions and methods for inactivation of pathogens at genital tract surfaces |
| EP2130531A1 (en) | 2008-06-04 | 2009-12-09 | Rolf Kullgren AB | Vaginal suppository comprising lactic acid |
| BRPI0803568B8 (pt) * | 2008-08-14 | 2021-05-25 | Biolab San Us Farm Ltda | composição mucoaderente |
| US20120070476A1 (en) | 2009-05-29 | 2012-03-22 | Moench Thomas R | Compositions and Methods for Inactivation of Pathogens at Genital Tract Surfaces |
| EP2440560A1 (en) | 2009-06-10 | 2012-04-18 | Ultimorphix Technologies B.v. | The succinate of tenofovir disoproxil |
| EP2704694A4 (en) | 2011-05-02 | 2014-11-19 | Aptalis Pharmatech Inc | RAPID DISSOLUTION TABLET COMPOSITIONS FOR VAGINAL DELIVERY |
| MX381271B (es) | 2011-06-28 | 2025-03-11 | Chemo Res Sl | Formulaciones mucoadhesivas en gel de alta dosificación de metronidazol de base acuosa y su uso para tratar la vaginosis bacteriana |
| SG11201405778WA (en) | 2012-03-19 | 2014-10-30 | Wolff August Gmbh & Co Kg Arzneimittel Dr | Use of amphoteric surfactants for the prevention and treatment of pathogenic vaginal biofilms in vaginal infections |
| NZ703203A (en) | 2012-06-13 | 2016-07-29 | Evofem Inc | Compositions and methods for enhancing the efficacy of contraceptive microbicides |
| JP2015528490A (ja) | 2012-09-14 | 2015-09-28 | シプラ・リミテッド | テノホビル、抗菌剤、及び任意にシクロピロックスを含む局所医薬組成物 |
| WO2015027071A1 (en) | 2013-08-21 | 2015-02-26 | Georgia Regents Research Institute, Inc. | Gpr81 agonists and methods thereof for promoting production of secretory iga |
| WO2015070072A1 (en) | 2013-11-07 | 2015-05-14 | Evofem, Inc. | Methods for manufacturing contraceptive microbicides with antiviral properties |
| JP2017501227A (ja) | 2013-12-19 | 2017-01-12 | エヴォフェム，インク． | アルギン酸をベースとする抗菌性化合物を使用して炎症と疾患を阻害するための組成物及び方法 |
| AU2015201042A1 (en) | 2014-02-28 | 2015-09-17 | Macfarlane Burnet Institute For Medical Research And Public Health Pty Ltd | Therapeutic Method |
| WO2018049326A1 (en) | 2016-09-12 | 2018-03-15 | Evofem Biosciences, Inc. | Combination gel for sexually transmitted infections |
| AU2017338748A1 (en) | 2016-10-04 | 2019-05-02 | Evofem Inc. | Method of treatment and prevention of bacterial vaginosis |
-
2013
- 2013-03-15 NZ NZ703203A patent/NZ703203A/en not_active IP Right Cessation
- 2013-03-15 EP EP17200193.5A patent/EP3308771A1/en not_active Withdrawn
- 2013-03-15 AU AU2013274815A patent/AU2013274815B2/en not_active Ceased
- 2013-03-15 SG SG11201408243VA patent/SG11201408243VA/en unknown
- 2013-03-15 BR BR112014030984-1A patent/BR112014030984B1/pt not_active IP Right Cessation
- 2013-03-15 CN CN201380030151.5A patent/CN104487054A/zh active Pending
- 2013-03-15 AP AP2014008149A patent/AP2014008149A0/xx unknown
- 2013-03-15 WO PCT/US2013/032510 patent/WO2013187984A1/en not_active Ceased
- 2013-03-15 UA UAA201500194A patent/UA115876C2/uk unknown
- 2013-03-15 MX MX2014015307A patent/MX365905B/es active IP Right Grant
- 2013-03-15 JP JP2015517245A patent/JP6352907B2/ja active Active
- 2013-03-15 EA EA201590008A patent/EA201590008A1/ru unknown
- 2013-03-15 HK HK15109540.9A patent/HK1208809A1/xx unknown
- 2013-03-15 EP EP13804259.3A patent/EP2861215A1/en not_active Withdrawn
- 2013-03-15 US US14/410,841 patent/US20150202216A1/en not_active Abandoned
- 2013-03-15 KR KR1020157000465A patent/KR102062599B1/ko active Active
- 2013-03-15 CN CN201910881646.8A patent/CN110693812A/zh active Pending
-
2014
- 2014-11-20 IL IL235812A patent/IL235812B/en active IP Right Grant
- 2014-12-11 MX MX2019007176A patent/MX2019007176A/es unknown
-
2015
- 2015-01-08 ZA ZA2015/00111A patent/ZA201500111B/en unknown
- 2015-09-24 US US14/864,673 patent/US9566232B2/en not_active Expired - Fee Related
-
2017
- 2017-01-19 US US15/410,632 patent/US20170128396A1/en not_active Abandoned
- 2017-07-19 AU AU2017206199A patent/AU2017206199B2/en not_active Ceased
-
2018
- 2018-02-16 JP JP2018026423A patent/JP6738573B2/ja active Active
-
2019
- 2019-01-03 US US16/239,314 patent/US10568855B2/en active Active
-
2020
- 2020-01-09 US US16/738,868 patent/US11439610B2/en active Active
-
2022
- 2022-08-29 US US17/823,020 patent/US11992472B2/en active Active
-
2024
- 2024-04-24 US US18/645,334 patent/US20240423936A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA202092456A2 (ru) | Комбинированная терапия, включающая ингибитор mdm2 и один или более дополнительных фармацевтически активных агентов, для лечения различных видов рака | |
| EA201591004A1 (ru) | Производные бороновой кислоты и их терапевтическое применение | |
| CL2017002792A1 (es) | Derivados de ciclohexano sustituido con amido | |
| ECSP12012349A (es) | Agentes inductores de apoptosis contra el cáncer y de enfermedades inmunes y autoinmunes | |
| ECSP12012348A (es) | Agentes inductores de apoptosis contra el cáncer y de enfermedades inmunes y autoinmunes | |
| EA201591003A1 (ru) | Производные бороновой кислоты и их терапевтическое применение | |
| UA115558C2 (uk) | Алкілпіримідинові похідні для лікування вірусних інфекцій та подальших захворювань | |
| EA201692301A1 (ru) | Производные бороновой кислоты и их терапевтическое применение | |
| MX2016015093A (es) | Derivados de acido boronico y sus usos terapeuticos. | |
| EP2709453A4 (en) | USE OF THIAZOLIDE COMPOUNDS FOR THE PREVENTION AND TREATMENT OF VIRUS DISEASES, CANCER AND DISEASES THROUGH INTRA-CELLULAR INFECTIONS | |
| EA201492290A1 (ru) | Составы и способы для вагинальной доставки антипрогестинов | |
| EA201590008A1 (ru) | Композиции и способы повышения эффективности бактерицидных средств контрацепции | |
| MX2015003262A (es) | Composicion farmaceutica topica. | |
| MX2016011667A (es) | Composiciones topicas que comprenden un extracto de coriolus versicolor para aumentar la autoinmunidad. | |
| EA201500851A1 (ru) | ЭСТРА-1,3,5(10),16-ТЕТРАЕН-3-КАРБОКСАМИДЫ ДЛЯ ИНГИБИРОВАНИЯ 17β-ГИДРОКСИСТЕРОИД-ДЕГИДРОГЕНАЗЫ (AKR1C3) | |
| AR091739A1 (es) | Composiciones y metodos para reducir el riesgo cardiometabolico | |
| CL2017002451A1 (es) | Compuestos heterocíclicos novedosos y su uso en la prevención o tratamiento de las infecciones bacterianas | |
| CL2017002803A1 (es) | Compuestos heterocíclicos y su uso en la prevención o tratamiento de las infecciones bacterianas | |
| MA38975A1 (fr) | Dispositif d'administration par voie intra-utérine | |
| MX2021001742A (es) | Composiciones y metodos para inhibir la inflamacion y las enfermedades utilizando un compuesto antimicrobiano con base en acido alginico. | |
| NZ746394A (en) | Compositions and methods of use of an inappetance-controlling compound | |
| MX2016004094A (es) | Composicion farmaceutica que comprende capecitabina y ciclofosfamida. | |
| MX2014011218A (es) | Uso de agentes tensoactivos anfotericos para la prevencion y tratamiento de biopeliculas vaginales patogenas en infecciones vaginales. | |
| CL2015002188A1 (es) | Agentes analgésicos oculares tópicos | |
| EA201491167A1 (ru) | Вагинальное кольцо, содержащее мелоксикам и агент для модулирования высвобождения активного ингредиента, для применения у женщин в качестве контрацептива для постоянного использования |